This could be due to dyslipidemia’s negative impact on the immune system, such as activation of inflammasomes [49], overproduction of the pro-inflammatory cytokine interleukin-6 [50], and reduction in serum immunoglobulin levels [51]. Here, IL6 is linked to metabolic syndrome.